OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS
Publication
, Journal Article
Guruiangan, S; Yan, H; Adamson, C; Shi, Q; McLendon, R; Bigner, D
Published in: NEURO-ONCOLOGY
April 1, 2009
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2009
Volume
11
Issue
2
Start / End Page
234 / 234
Location
Tokyo, JAPAN
Publisher
DUKE UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Guruiangan, S., Yan, H., Adamson, C., Shi, Q., McLendon, R., & Bigner, D. (2009). OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS. NEURO-ONCOLOGY, 11(2), 234–234.
Guruiangan, Sridharan, Hai Yan, Cory Adamson, Qun Shi, Roger McLendon, and Darell Bigner. “OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS.” NEURO-ONCOLOGY 11, no. 2 (April 1, 2009): 234–234.
Guruiangan S, Yan H, Adamson C, Shi Q, McLendon R, Bigner D. OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS. NEURO-ONCOLOGY. 2009 Apr 1;11(2):234–234.
Guruiangan, Sridharan, et al. “OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS.” NEURO-ONCOLOGY, vol. 11, no. 2, DUKE UNIV PRESS, Apr. 2009, pp. 234–234.
Guruiangan S, Yan H, Adamson C, Shi Q, McLendon R, Bigner D. OTX2 IS ONCOGENIC AND PREDICTS DECREASED SURVIVAL IN MEDULLOBLASTOMA PATIENTS. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2009 Apr 1;11(2):234–234.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2009
Volume
11
Issue
2
Start / End Page
234 / 234
Location
Tokyo, JAPAN
Publisher
DUKE UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences